Share Price and Basic Stock Data
Last Updated: February 6, 2026, 8:34 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cerebra Integrated Technologies Ltd operates in the IT Networking Equipment industry, with its share price currently standing at ₹6.07 and a market capitalization of ₹71.7 Cr. The company’s revenue trajectory has experienced significant fluctuations, with sales reported at ₹29.43 Cr in September 2022, declining sharply to ₹6.85 Cr by June 2023. A slight recovery was noted in subsequent quarters, with sales rising to ₹17.94 Cr in September 2023. However, the overall trend reveals a worrying decline, with revenues further expected to hover around ₹10.17 Cr by June 2024. The company’s sales for the trailing twelve months (TTM) totaled ₹17 Cr, indicating a severe contraction compared to historical highs, which raises concerns about its competitive positioning in the market.
Profitability and Efficiency Metrics
Cerebra’s profitability metrics are concerning, highlighted by an operating profit margin (OPM) of -478.73% as of September 2025, a stark contrast to the positive margins seen in prior years. The company recorded a net profit loss of ₹40 Cr, reflecting ongoing challenges in cost management and revenue generation. The interest coverage ratio (ICR) stood at -5.46x, indicating significant difficulties in meeting interest obligations, which could further strain operational viability. Return on equity (ROE) was reported at 16.9%, but the return on capital employed (ROCE) declined to 15.4%, suggesting inefficiency in utilizing capital. These figures illustrate a critical need for operational restructuring and a reevaluation of business strategies to enhance profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Cerebra Integrated Technologies reveals a precarious financial position. The company reported total borrowings of ₹41 Cr against reserves of ₹29 Cr, resulting in a debt-to-equity ratio of 0.24, which is relatively low compared to industry norms. However, the cash conversion cycle (CCC) of 749 days raises concerns about liquidity and operational efficiency. The price-to-book value ratio (P/BV) stood at 0.27x, indicating that the stock is undervalued compared to its book value, which might attract value investors. Nonetheless, the declining net profit and rising losses, as evidenced by a net profit margin of -132.71%, signal a potential liquidity crisis that could hinder future growth prospects.
Shareholding Pattern and Investor Confidence
Cerebra’s shareholding pattern indicates a strong public presence, with public shareholders holding 99.10% of the equity, while promoter holdings remained low at 0.84%. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), have minimal stake, with FIIs at 0.00% and DIIs at 0.01%, reflecting a lack of confidence from institutional players. The number of shareholders as of September 2025 was 37,233, which suggests a broad retail investor base. However, the low promoter holding and institutional interest may deter long-term investors, as they often seek management commitment to align with shareholder interests. The recent decline in net profit and operational challenges could further erode investor confidence.
Outlook, Risks, and Final Insight
The outlook for Cerebra Integrated Technologies is fraught with challenges, primarily due to its declining revenue and profitability metrics. The company must address its operational inefficiencies and improve its sales performance to stabilize its financial health. Risks include potential liquidity issues stemming from a high cash conversion cycle and increasing operational losses, which could hinder future growth and attract negative market sentiment. Strengths, however, lie in its low debt levels and the potential for a turnaround if strategic measures are effectively implemented. If Cerebra can successfully pivot its operations and regain market competitiveness, there may be opportunities for recovery; conversely, failure to address these critical issues may lead to further deterioration in its financial standing.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Computer Point Ltd | 12.7 Cr. | 4.23 | 6.79/3.70 | 11.0 | 0.00 % | 0.06 % | 0.36 % | 10.0 | |
| Brisk Technovision Ltd | 15.1 Cr. | 75.5 | 132/71.0 | 27.0 | 35.9 | 3.97 % | 18.8 % | 14.0 % | 10.0 |
| Benchmark Computer Solutions Ltd | 18.1 Cr. | 26.4 | 39.1/23.6 | 8.28 | 41.6 | 0.00 % | 8.11 % | 6.44 % | 10.0 |
| ACI Infocom Ltd | 11.8 Cr. | 1.07 | 2.50/0.89 | 1.47 | 0.00 % | 5.89 % | 5.83 % | 1.00 | |
| TVS Electronics Ltd | 734 Cr. | 396 | 741/271 | 49.0 | 0.00 % | 1.88 % | 5.61 % | 10.0 | |
| Industry Average | 1,200.63 Cr | 330.82 | 26.24 | 106.37 | 0.76% | 14.23% | 11.91% | 7.00 |
All Competitor Stocks of Cerebra Integrated Technologies Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.43 | 13.04 | 13.30 | 6.85 | 17.94 | 11.98 | 15.21 | 10.17 | 12.18 | 10.74 | 2.52 | 1.79 | 2.21 |
| Expenses | 25.32 | 10.96 | 14.79 | 13.48 | 30.79 | 31.99 | 18.33 | 19.22 | 21.40 | 25.49 | 4.00 | 6.07 | 12.79 |
| Operating Profit | 4.11 | 2.08 | -1.49 | -6.63 | -12.85 | -20.01 | -3.12 | -9.05 | -9.22 | -14.75 | -1.48 | -4.28 | -10.58 |
| OPM % | 13.97% | 15.95% | -11.20% | -96.79% | -71.63% | -167.03% | -20.51% | -88.99% | -75.70% | -137.34% | -58.73% | -239.11% | -478.73% |
| Other Income | -0.15 | 0.03 | 0.41 | 0.02 | 0.01 | -7.96 | 1.31 | 0.04 | -9.67 | -2.03 | -3.65 | -9.55 | -0.22 |
| Interest | 2.32 | 1.53 | 3.45 | 1.62 | 1.68 | 1.71 | 0.96 | 1.52 | 1.63 | 1.56 | 1.58 | 1.63 | 1.88 |
| Depreciation | 0.10 | 0.10 | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | 0.10 | 0.10 | 0.10 | 0.15 | 0.10 | 0.10 |
| Profit before tax | 1.54 | 0.48 | -4.65 | -8.34 | -14.63 | -29.79 | -2.88 | -10.63 | -20.62 | -18.44 | -6.86 | -15.56 | -12.78 |
| Tax % | 22.08% | 22.92% | -62.58% | 0.00% | 10.46% | 0.00% | -306.25% | 0.00% | 0.00% | -54.99% | 12.68% | -9.32% | -24.49% |
| Net Profit | 1.20 | 0.38 | -1.74 | -8.34 | -16.16 | -29.78 | 5.95 | -10.63 | -20.62 | -8.29 | -7.72 | -14.10 | -9.65 |
| EPS in Rs | 0.10 | 0.03 | -0.14 | -0.69 | -1.33 | -2.46 | 0.49 | -0.88 | -1.70 | -0.68 | -0.64 | -1.16 | -0.80 |
Last Updated: January 2, 2026, 2:59 am
Below is a detailed analysis of the quarterly data for Cerebra Integrated Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 2.21 Cr.. The value appears strong and on an upward trend. It has increased from 1.79 Cr. (Jun 2025) to 2.21 Cr., marking an increase of 0.42 Cr..
- For Expenses, as of Sep 2025, the value is 12.79 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.07 Cr. (Jun 2025) to 12.79 Cr., marking an increase of 6.72 Cr..
- For Operating Profit, as of Sep 2025, the value is -10.58 Cr.. The value appears to be declining and may need further review. It has decreased from -4.28 Cr. (Jun 2025) to -10.58 Cr., marking a decrease of 6.30 Cr..
- For OPM %, as of Sep 2025, the value is -478.73%. The value appears to be declining and may need further review. It has decreased from -239.11% (Jun 2025) to -478.73%, marking a decrease of 239.62%.
- For Other Income, as of Sep 2025, the value is -0.22 Cr.. The value appears strong and on an upward trend. It has increased from -9.55 Cr. (Jun 2025) to -0.22 Cr., marking an increase of 9.33 Cr..
- For Interest, as of Sep 2025, the value is 1.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.63 Cr. (Jun 2025) to 1.88 Cr., marking an increase of 0.25 Cr..
- For Depreciation, as of Sep 2025, the value is 0.10 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.10 Cr..
- For Profit before tax, as of Sep 2025, the value is -12.78 Cr.. The value appears strong and on an upward trend. It has increased from -15.56 Cr. (Jun 2025) to -12.78 Cr., marking an increase of 2.78 Cr..
- For Tax %, as of Sep 2025, the value is -24.49%. The value appears to be improving (decreasing) as expected. It has decreased from -9.32% (Jun 2025) to -24.49%, marking a decrease of 15.17%.
- For Net Profit, as of Sep 2025, the value is -9.65 Cr.. The value appears strong and on an upward trend. It has increased from -14.10 Cr. (Jun 2025) to -9.65 Cr., marking an increase of 4.45 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.80. The value appears strong and on an upward trend. It has increased from -1.16 (Jun 2025) to -0.80, marking an increase of 0.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 130 | 267 | 238 | 250 | 314 | 385 | 182 | 70 | 231 | 86 | 50 | 36 | 17 |
| Expenses | 128 | 261 | 236 | 237 | 272 | 343 | 149 | 61 | 188 | 76 | 88 | 70 | 48 |
| Operating Profit | 3 | 7 | 2 | 13 | 42 | 42 | 33 | 9 | 42 | 10 | -38 | -35 | -31 |
| OPM % | 2% | 3% | 1% | 5% | 13% | 11% | 18% | 12% | 18% | 11% | -75% | -97% | -180% |
| Other Income | 1 | 0 | 3 | 1 | 2 | -18 | -15 | 0 | 5 | 0 | -12 | -15 | -15 |
| Interest | 1 | 3 | 3 | 1 | 2 | 4 | 3 | 4 | 6 | 10 | 6 | 6 | 7 |
| Depreciation | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 3 | 2 | 13 | 42 | 20 | 14 | 4 | 40 | 0 | -56 | -57 | -54 |
| Tax % | 12% | 11% | 17% | 7% | 17% | 71% | 15% | 68% | 32% | -1,475% | -13% | -16% | |
| Net Profit | 2 | 2 | 2 | 12 | 35 | 6 | 12 | 1 | 27 | 3 | -48 | -47 | -40 |
| EPS in Rs | 0.30 | 0.22 | 0.17 | 1.04 | 2.69 | 0.36 | 0.94 | 0.14 | 2.26 | 0.21 | -3.99 | -3.90 | -3.28 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 500.00% | 191.67% | -82.86% | 100.00% | -91.67% | 2600.00% | -88.89% | -1700.00% | 2.08% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 500.00% | -308.33% | -274.52% | 182.86% | -191.67% | 2691.67% | -2688.89% | -1611.11% | 1702.08% |
Cerebra Integrated Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | -28% |
| 3 Years: | -46% |
| TTM: | -51% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -25% |
| 3 Years: | -47% |
| 1 Year: | -51% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | -9% |
| Last Year: | -14% |
Last Updated: September 5, 2025, 1:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:06 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 48 | 84 | 96 | 108 | 120 | 121 | 121 | 121 | 112 | 112 | 112 | 112 | 112 |
| Reserves | 45 | 49 | 52 | 66 | 136 | 147 | 173 | 171 | 146 | 148 | 100 | 53 | 29 |
| Borrowings | 7 | 40 | 19 | 3 | 3 | 4 | 13 | 18 | 32 | 41 | 39 | 40 | 41 |
| Other Liabilities | 79 | 59 | 14 | 155 | 104 | 193 | 141 | 73 | 135 | 98 | 101 | 53 | 50 |
| Total Liabilities | 178 | 231 | 181 | 332 | 363 | 466 | 448 | 384 | 425 | 399 | 352 | 258 | 233 |
| Fixed Assets | 8 | 7 | 6 | 6 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 12 | 12 |
| CWIP | 0 | 0 | 0 | 3 | 0 | 0 | 68 | 73 | 3 | 3 | 3 | 0 | 0 |
| Investments | 0 | 0 | 1 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 170 | 224 | 174 | 323 | 340 | 456 | 371 | 301 | 412 | 386 | 340 | 246 | 221 |
| Total Assets | 178 | 231 | 181 | 332 | 363 | 466 | 448 | 384 | 425 | 399 | 352 | 258 | 233 |
Below is a detailed analysis of the balance sheet data for Cerebra Integrated Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 112.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 112.00 Cr..
- For Reserves, as of Sep 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 24.00 Cr..
- For Borrowings, as of Sep 2025, the value is 41.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 40.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 50.00 Cr.. The value appears to be improving (decreasing). It has decreased from 53.00 Cr. (Mar 2025) to 50.00 Cr., marking a decrease of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 233.00 Cr.. The value appears to be improving (decreasing). It has decreased from 258.00 Cr. (Mar 2025) to 233.00 Cr., marking a decrease of 25.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 221.00 Cr.. The value appears to be declining and may need further review. It has decreased from 246.00 Cr. (Mar 2025) to 221.00 Cr., marking a decrease of 25.00 Cr..
- For Total Assets, as of Sep 2025, the value is 233.00 Cr.. The value appears to be declining and may need further review. It has decreased from 258.00 Cr. (Mar 2025) to 233.00 Cr., marking a decrease of 25.00 Cr..
However, the Borrowings (41.00 Cr.) are higher than the Reserves (29.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.00 | -33.00 | -17.00 | 10.00 | 39.00 | 38.00 | 20.00 | -9.00 | 10.00 | -31.00 | -77.00 | -75.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 310 | 134 | 96 | 315 | 233 | 321 | 499 | 889 | 299 | 596 | 876 | 759 |
| Inventory Days | 39 | 26 | 4 | 4 | 22 | 5 | 34 | 212 | 48 | 269 | 237 | 129 |
| Days Payable | 208 | 72 | 16 | 247 | 134 | 193 | 302 | 290 | 186 | 310 | 430 | 138 |
| Cash Conversion Cycle | 140 | 87 | 84 | 71 | 121 | 133 | 231 | 811 | 161 | 556 | 683 | 749 |
| Working Capital Days | 139 | 80 | 77 | 93 | 139 | 153 | 265 | 618 | 136 | 370 | 372 | 306 |
| ROCE % | 4% | 3% | 8% | 20% | 17% | 12% | 3% | 15% | 3% | -13% | -15% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -4.22 | -4.32 | 2.45 | 2.45 | 0.10 |
| Diluted EPS (Rs.) | -4.22 | -4.32 | 2.31 | 2.31 | 0.10 |
| Cash EPS (Rs.) | -4.18 | -4.28 | 0.26 | 2.49 | 0.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.72 | 18.75 | 23.06 | 22.84 | 24.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.72 | 18.75 | 23.06 | 22.84 | 24.62 |
| Revenue From Operations / Share (Rs.) | 3.18 | 4.64 | 7.70 | 20.63 | 5.77 |
| PBDIT / Share (Rs.) | -3.07 | -3.23 | 0.91 | 4.21 | 0.72 |
| PBIT / Share (Rs.) | -3.11 | -3.27 | 0.88 | 4.17 | 0.68 |
| PBT / Share (Rs.) | -5.05 | -4.97 | 0.01 | 3.61 | 0.32 |
| Net Profit / Share (Rs.) | -4.22 | -4.32 | 0.22 | 2.45 | 0.10 |
| NP After MI And SOA / Share (Rs.) | -4.22 | -4.32 | 0.22 | 2.45 | 0.13 |
| PBDIT Margin (%) | -96.50 | -69.68 | 11.94 | 20.40 | 12.54 |
| PBIT Margin (%) | -97.75 | -70.50 | 11.45 | 20.21 | 11.92 |
| PBT Margin (%) | -158.75 | -106.98 | 0.17 | 17.51 | 5.59 |
| Net Profit Margin (%) | -132.71 | -92.97 | 2.91 | 11.86 | 1.76 |
| NP After MI And SOA Margin (%) | -132.70 | -92.96 | 2.92 | 11.86 | 2.42 |
| Return on Networth / Equity (%) | -28.67 | -22.78 | 0.96 | 10.63 | 0.57 |
| Return on Capital Employeed (%) | -21.38 | -17.44 | 3.81 | 18.22 | 2.78 |
| Return On Assets (%) | -18.29 | -13.71 | 0.63 | 6.45 | 0.44 |
| Total Debt / Equity (X) | 0.24 | 0.18 | 0.15 | 0.12 | 0.05 |
| Asset Turnover Ratio (%) | 0.11 | 0.13 | 0.20 | 0.56 | 0.17 |
| Current Ratio (X) | 1.32 | 1.37 | 1.64 | 1.52 | 2.51 |
| Quick Ratio (X) | 1.21 | 1.15 | 1.31 | 1.39 | 2.20 |
| Inventory Turnover Ratio (X) | 1.76 | 1.24 | 1.80 | 7.05 | 0.65 |
| Interest Coverage Ratio (X) | -5.46 | -6.07 | 1.08 | 7.54 | 1.98 |
| Interest Coverage Ratio (Post Tax) (X) | -4.06 | -4.92 | 1.28 | 5.39 | 1.28 |
| Enterprise Value (Cr.) | 82.41 | 107.12 | 117.47 | 911.09 | 640.14 |
| EV / Net Operating Revenue (X) | 2.31 | 2.06 | 1.36 | 3.94 | 9.15 |
| EV / EBITDA (X) | -2.40 | -2.96 | 11.41 | 19.32 | 72.97 |
| MarketCap / Net Operating Revenue (X) | 1.26 | 1.37 | 0.93 | 3.82 | 8.92 |
| Price / BV (X) | 0.27 | 0.33 | 0.31 | 3.42 | 2.13 |
| Price / Net Operating Revenue (X) | 1.26 | 1.37 | 0.93 | 3.82 | 8.93 |
| EarningsYield | -1.05 | -0.67 | 0.03 | 0.03 | 0.00 |
After reviewing the key financial ratios for Cerebra Integrated Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 5. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 5. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For Cash EPS (Rs.), as of Mar 25, the value is -4.18. This value is below the healthy minimum of 3. It has increased from -4.28 (Mar 24) to -4.18, marking an increase of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.72. It has decreased from 18.75 (Mar 24) to 14.72, marking a decrease of 4.03.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.72. It has decreased from 18.75 (Mar 24) to 14.72, marking a decrease of 4.03.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3.18. It has decreased from 4.64 (Mar 24) to 3.18, marking a decrease of 1.46.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -3.07. This value is below the healthy minimum of 2. It has increased from -3.23 (Mar 24) to -3.07, marking an increase of 0.16.
- For PBIT / Share (Rs.), as of Mar 25, the value is -3.11. This value is below the healthy minimum of 0. It has increased from -3.27 (Mar 24) to -3.11, marking an increase of 0.16.
- For PBT / Share (Rs.), as of Mar 25, the value is -5.05. This value is below the healthy minimum of 0. It has decreased from -4.97 (Mar 24) to -5.05, marking a decrease of 0.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 2. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 2. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For PBDIT Margin (%), as of Mar 25, the value is -96.50. This value is below the healthy minimum of 10. It has decreased from -69.68 (Mar 24) to -96.50, marking a decrease of 26.82.
- For PBIT Margin (%), as of Mar 25, the value is -97.75. This value is below the healthy minimum of 10. It has decreased from -70.50 (Mar 24) to -97.75, marking a decrease of 27.25.
- For PBT Margin (%), as of Mar 25, the value is -158.75. This value is below the healthy minimum of 10. It has decreased from -106.98 (Mar 24) to -158.75, marking a decrease of 51.77.
- For Net Profit Margin (%), as of Mar 25, the value is -132.71. This value is below the healthy minimum of 5. It has decreased from -92.97 (Mar 24) to -132.71, marking a decrease of 39.74.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -132.70. This value is below the healthy minimum of 8. It has decreased from -92.96 (Mar 24) to -132.70, marking a decrease of 39.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is -28.67. This value is below the healthy minimum of 15. It has decreased from -22.78 (Mar 24) to -28.67, marking a decrease of 5.89.
- For Return on Capital Employeed (%), as of Mar 25, the value is -21.38. This value is below the healthy minimum of 10. It has decreased from -17.44 (Mar 24) to -21.38, marking a decrease of 3.94.
- For Return On Assets (%), as of Mar 25, the value is -18.29. This value is below the healthy minimum of 5. It has decreased from -13.71 (Mar 24) to -18.29, marking a decrease of 4.58.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 0.24, marking an increase of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.11. It has decreased from 0.13 (Mar 24) to 0.11, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has decreased from 1.37 (Mar 24) to 1.32, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 4. It has increased from 1.24 (Mar 24) to 1.76, marking an increase of 0.52.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -5.46. This value is below the healthy minimum of 3. It has increased from -6.07 (Mar 24) to -5.46, marking an increase of 0.61.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -4.06. This value is below the healthy minimum of 3. It has increased from -4.92 (Mar 24) to -4.06, marking an increase of 0.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 82.41. It has decreased from 107.12 (Mar 24) to 82.41, marking a decrease of 24.71.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.06 (Mar 24) to 2.31, marking an increase of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is -2.40. This value is below the healthy minimum of 5. It has increased from -2.96 (Mar 24) to -2.40, marking an increase of 0.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.26, marking a decrease of 0.11.
- For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 24) to 0.27, marking a decrease of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.26, marking a decrease of 0.11.
- For EarningsYield, as of Mar 25, the value is -1.05. This value is below the healthy minimum of 5. It has decreased from -0.67 (Mar 24) to -1.05, marking a decrease of 0.38.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cerebra Integrated Technologies Ltd:
- Net Profit Margin: -132.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -21.38% (Industry Average ROCE: 14.23%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -28.67% (Industry Average ROE: 11.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -4.06
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 26.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.24
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -132.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Networking Equipment | #S-5, Off 3rd Cross, 1 Stage, Pennya Industrial Area, Bengaluru Karnataka 560058 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. V Ranganathan | Chairman & Managing Director |
| Mr. P Vishwamurthy | WholeTime Director & CFO |
| Mr. Ramkripal Prashant Verma | Independent Director |
| Mr. Afzalkhan Usmankhan Afridi | Independent Director |
| Ms. Afjalbhai Allarakhabhai Roomi | Independent Director |
| Mr. Kiran Murthi | Independent Director |
| Mr. Vasudevan Padmanabhan Nair | Independent Director |
| Mr. Jignesh J Mehta | Independent Director |
| Ms. Ruma Chatterjee | Independent Director |
FAQ
What is the intrinsic value of Cerebra Integrated Technologies Ltd?
Cerebra Integrated Technologies Ltd's intrinsic value (as of 07 February 2026) is ₹16.49 which is 207.08% higher the current market price of ₹5.37, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹62.3 Cr. market cap, FY2025-2026 high/low of ₹10.1/3.99, reserves of ₹29 Cr, and liabilities of ₹233 Cr.
What is the Market Cap of Cerebra Integrated Technologies Ltd?
The Market Cap of Cerebra Integrated Technologies Ltd is 62.3 Cr..
What is the current Stock Price of Cerebra Integrated Technologies Ltd as on 07 February 2026?
The current stock price of Cerebra Integrated Technologies Ltd as on 07 February 2026 is ₹5.37.
What is the High / Low of Cerebra Integrated Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cerebra Integrated Technologies Ltd stocks is ₹10.1/3.99.
What is the Stock P/E of Cerebra Integrated Technologies Ltd?
The Stock P/E of Cerebra Integrated Technologies Ltd is .
What is the Book Value of Cerebra Integrated Technologies Ltd?
The Book Value of Cerebra Integrated Technologies Ltd is 11.6.
What is the Dividend Yield of Cerebra Integrated Technologies Ltd?
The Dividend Yield of Cerebra Integrated Technologies Ltd is 0.00 %.
What is the ROCE of Cerebra Integrated Technologies Ltd?
The ROCE of Cerebra Integrated Technologies Ltd is 15.4 %.
What is the ROE of Cerebra Integrated Technologies Ltd?
The ROE of Cerebra Integrated Technologies Ltd is 16.9 %.
What is the Face Value of Cerebra Integrated Technologies Ltd?
The Face Value of Cerebra Integrated Technologies Ltd is 10.0.